Invex Therapeutics Ltd (IXC.AX)
AUD 0.06
(0.0%)
AUD 0.06
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 431.63 Thousand AUD | -72.55% |
| 2023 | 1.57 Million AUD | 56.58% |
| 2022 | 1 Million AUD | 52.47% |
| 2021 | 658.61 Thousand AUD | -67.32% |
| 2020 | 2.01 Million AUD | 115.43% |
| 2019 | 935.49 Thousand AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 FY | 431.63 Thousand AUD | -72.55% |
| 2024 Q2 | 984.57 Thousand AUD | 0.0% |
| 2024 Q4 | 431.63 Thousand AUD | 0.0% |
| 2023 Q1 | 1.16 Million AUD | 15.68% |
| 2023 Q4 | 1.57 Million AUD | 0.0% |
| 2023 Q2 | 1.16 Million AUD | 0.0% |
| 2023 Q3 | 1.57 Million AUD | 35.36% |
| 2023 FY | 1.57 Million AUD | 56.58% |
| 2022 FY | 1 Million AUD | 52.47% |
| 2022 Q4 | 1 Million AUD | 0.0% |
| 2022 Q3 | 1 Million AUD | 3.96% |
| 2022 Q2 | 966 Thousand AUD | 0.0% |
| 2022 Q1 | 966 Thousand AUD | 46.67% |
| 2021 Q1 | 634.14 Thousand AUD | -68.53% |
| 2021 FY | 658.61 Thousand AUD | -67.32% |
| 2021 Q4 | 658.61 Thousand AUD | 0.0% |
| 2021 Q3 | 658.61 Thousand AUD | 3.86% |
| 2021 Q2 | 634.14 Thousand AUD | 0.0% |
| 2020 Q3 | 2.01 Million AUD | 276.41% |
| 2020 Q2 | 535.41 Thousand AUD | 0.0% |
| 2020 Q1 | 535.41 Thousand AUD | 0.0% |
| 2020 FY | 2.01 Million AUD | 115.43% |
| 2020 Q4 | 2.01 Million AUD | 0.0% |
| 2019 FY | 935.49 Thousand AUD | 0.0% |
| 2019 Q3 | 40.29 Thousand AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Anatara Lifesciences Ltd | 306.84 Thousand AUD | -40.665% |
| BTC Health Limited | 203.94 Thousand AUD | -111.637% |
| CSL Limited | 27.88 Billion AUD | 99.998% |
| Clarity Pharmaceuticals Ltd | 8.33 Million AUD | 94.819% |
| Clinuvel Pharmaceuticals Limited | 28.11 Million AUD | 98.465% |
| Island Pharmaceuticals Limited | 1.04 Million AUD | 58.72% |
| Orthocell Limited | 22.08 Million AUD | 98.045% |
| Proteomics International Laboratories Limited | 1.62 Million AUD | 73.453% |
| Race Oncology Limited | 1.91 Million AUD | 77.477% |
| Starpharma Holdings Limited | 8.69 Million AUD | 95.038% |
| AdAlta Limited | 3.54 Million AUD | 87.816% |
| Zelira Therapeutics Limited | 9.35 Million AUD | 95.387% |
| Memphasys Limited | 5.59 Million AUD | 92.282% |
| NeuroScientific Biopharmaceuticals Limited | 85.68 Thousand AUD | -403.752% |
| Acrux Limited | 5.68 Million AUD | 92.41% |
| Bio-Gene Technology Limited | 368.44 Thousand AUD | -17.149% |
| Botanix Pharmaceuticals Limited | 3.73 Million AUD | 88.435% |
| Cynata Therapeutics Limited | 1.17 Million AUD | 63.142% |
| Nyrada Inc. | 855.63 Thousand AUD | 49.554% |
| PharmAust Limited | 896.6 Thousand AUD | 51.86% |
| Radiopharm Theranostics Limited | 44.68 Million AUD | 99.034% |
| Arovella Therapeutics Limited | 2.05 Million AUD | 79.013% |
| Alterity Therapeutics Limited | 5.42 Million AUD | 92.045% |
| Amplia Therapeutics Limited | 3.42 Million AUD | 87.404% |
| Biome Australia Limited | 5.37 Million AUD | 91.967% |
| Biotron Limited | 737.5 Thousand AUD | 41.475% |
| Chimeric Therapeutics Limited | 12.8 Million AUD | 96.629% |
| EZZ Life Science Holdings Limited | 4.22 Million AUD | 89.794% |
| Immutep Limited | 10.97 Million AUD | 96.069% |
| Imugene Limited | 33.14 Million AUD | 98.698% |
| Noxopharm Limited | 1.28 Million AUD | 66.504% |
| Patrys Limited | 691.36 Thousand AUD | 37.568% |
| Prescient Therapeutics Limited | 2.32 Million AUD | 81.44% |
| PYC Therapeutics Limited | 10.18 Million AUD | 95.762% |
| Telix Pharmaceuticals Limited | 249.39 Million AUD | 99.827% |
| Dimerix Limited | 13.89 Million AUD | 96.893% |
| Hexima Limited | 248.67 Thousand AUD | -73.575% |
| Neuren Pharmaceuticals Limited | 42.76 Million AUD | 98.991% |
| Nanollose Limited | 465.64 Thousand AUD | 7.305% |
| Tissue Repair Ltd | 1.35 Million AUD | 68.049% |
| AnteoTech Limited | 4.07 Million AUD | 89.409% |
| Paradigm Biopharmaceuticals Limited | 3.58 Million AUD | 87.958% |
| Recce Pharmaceuticals Ltd | 15.89 Million AUD | 97.284% |
| Avecho Biotechnology Limited | 941.54 Thousand AUD | 54.157% |
| Actinogen Medical Limited | 1.61 Million AUD | 73.28% |
| Immuron Limited | 2.84 Million AUD | 84.805% |
| Argenica Therapeutics Limited | 2.42 Million AUD | 82.213% |